Accelerate Diagnostics Inc reports results for the quarter ended in September - Earnings Summary

Accelerate Diagnostics

14/11/2022 22:04

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 19 cents per share.
    * Revenue fell 5.2% to $2.96 million from a year ago;
analysts
expected $3.75 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of 18 cents​.
    * The mean earnings estimate of analysts had risen by
about 30.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Accelerate Diagnostics Inc shares had fallen by 6.6% this
quarter and lost 72.8% so far this year.
    * The company reported a quarterly loss of $15.71 million.
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.19          -0.18          Beat
 Jun. 30 2022      -0.28          -0.23          Beat
 Mar. 31 2022      -0.30          -0.21          Beat
 Dec. 31 2021      -0.25          -0.35          Missed